ALPHA TAU MEDICAL LTD (DRTS) Stock Income Statement
NASDAQ:DRTS - Nasdaq - IL0011839383 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 36.04M | 35.68M | 32.14M | 13.79M | 9.24M | |||
| Research and Development | 27.02M | 26.42M | 20.89M | 11.45M | 7.54M | |||
| Selling, General, and Administrative Expenses | 9.02M | 9.71M | 11.25M | 2.34M | 1.70M | |||
| Operating Income | -36.04M | -35.68M | -32.14M | -13.79M | -9.24M | |||
| Interest Income/Expense | 4.08M | 4.54M | 2.20M | -200.00K | 710.00K | |||
| Other Income/Expense | 218.00K | 1.99M | -3.81M | -13.27M | -190.00K | |||
| Income Before Taxes | -31.74M | -29.14M | -33.74M | -27.26M | -8.72M | |||
| Income Tax | 6.00K | 16.00K | 20.00K | 10.00K | 160.00K | |||
| Net Income | -31.75M | -29.16M | -33.76M | -27.27M | -8.88M | |||
| EBITDA | -34.94M | -34.61M | -31.16M | -13.01M | -9.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | |||
| Non GAAP EPS | -0.45 | -0.42 | -0.66 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD